<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3145">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04686409</url>
  </required_header>
  <id_info>
    <org_study_id>CoCoV</org_study_id>
    <nct_id>NCT04686409</nct_id>
  </id_info>
  <brief_title>App-based Symptom Tracking After Corona Vaccination (CoCoV)</brief_title>
  <official_title>App-based Symptom Tracking After Corona Vaccination (CoCoV)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Ulm</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Ulm</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study investigates the side effects of different COVID-19 vaccines.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this observational study side effects of COVID-19 vaccines will be documented using an&#xD;
      open-source mobile application. Participants are invited to answer a questionnaire on a daily&#xD;
      basis. Common and unknown events are queried and collected. The primary result of this study&#xD;
      will be a descriptive analysis of the collected data.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 11, 2021</start_date>
  <completion_date type="Anticipated">August 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with treatment-related side effects</measure>
    <time_frame>4 weeks</time_frame>
    <description>Number of participants with treatment-related side effects as assessed by the toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials (status September 2007)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Distribution and deviation of documented side effects</measure>
    <time_frame>4 weeks</time_frame>
    <description>Descriptive statistics for different side effects</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Adverse Events in COVID-19 Vaccination</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>COVID-19 vaccines</intervention_name>
    <description>Participants will be vaccinated with one of the approved COVID-19 vaccines</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult volunteers (≥ 18 years) who received a COVID-19 vaccination.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  received COVID-19 vaccination&#xD;
&#xD;
          -  age ≥ 18 years&#xD;
&#xD;
          -  mobile device (iOS or Android)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No knowledge of German or English language&#xD;
&#xD;
          -  No written informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Seufferlein, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Ulm</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Seufferlein, Prof. Dr.</last_name>
    <phone>+4973150044501</phone>
    <email>thomas.seufferlein@uniklinik-ulm.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universitätsklinikum Ulm</name>
      <address>
        <city>Ulm</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 22, 2020</study_first_submitted>
  <study_first_submitted_qc>December 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 28, 2020</study_first_posted>
  <last_update_submitted>December 22, 2020</last_update_submitted>
  <last_update_submitted_qc>December 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Ulm</investigator_affiliation>
    <investigator_full_name>Thomas Seufferlein</investigator_full_name>
    <investigator_title>Professor, Head of Department</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

